Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (69)

2024

  1. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry

    British Journal of Dermatology, Vol. 190, Núm. 3, pp. 355-363

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594

  3. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)

    Actas Dermo-Sifiliograficas

  4. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298

  5. [Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T479-T487

2022

  1. Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

    Dermatology, Vol. 238, Núm. 2, pp. 320-328

  2. Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)

    Journal of the European Academy of Dermatology and Venereology

  3. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer –Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 451-458

2021

  1. Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature

    Experimental dermatology, Vol. 30, Núm. 5, pp. 717-722

2020

  1. State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS)

    International Journal of Dermatology, Vol. 59, Núm. 3, pp. 321-325

  2. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538

2014

  1. Current dystrophic epidermolysis bullosa research does not match research needs perceived by patients and clinicians

    Journal of the American Academy of Dermatology, Vol. 71, Núm. 5, pp. 1008-1011

  2. Description of dermatological hospitalization in Spain (2005-2010). Population-based data from the minimum data set

    Piel, Vol. 29, Núm. 9, pp. 546-551

  3. The Use of systematic reviews in clinical trials and narrative reviews in dermatology: Is the best evidence being used?

    Actas Dermo-Sifiliograficas, Vol. 105, Núm. 3, pp. 295-299

2013

  1. Usefulness of cochrane skin group reviews for clinical practice

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 8, pp. 679-684

2012

  1. Products for hand hygiene and antisepsis: Use by health professionals and relationship with hand eczema

    Actas Dermo-Sifiliograficas, Vol. 103, Núm. 3, pp. 192-197

  2. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: Patients ineligible vs eligible for randomized controlled trials

    Archives of Dermatology, Vol. 148, Núm. 4, pp. 463-470

  3. The contribution of dermatological registries: Past and future

    Piel, Vol. 27, Núm. 5, pp. 231-233

2011

  1. Chloroquine-induced myopathy

    Lupus